<![CDATA[Trigeminal neuralgia is characterized by severe pain that is restricted to the trigeminal nerve and frequently causes abrupt, severe bouts in the face. About 80% of cases of classical trigeminal neuralgia are classed as idiopathic. With the use of the Numeric Rating Scale (NRS) and the SF-36 questionnaire, this case study aims to determine how perineural injection therapy (PIT) affects pain relief in early trigeminal neuralgia cases and how it can affect patient function. The patient presented with a history of 8 years persistent facial pain, localized to the right side of the face. Described as sharp and intermittent, the pain rated between 6 on the Numeric Rating Scale (NRS). It was exacerbated by activities such as chewing and combing, yet alleviated by rest and medication. Injections of a 5% dextrose solution in sterile water (D5W) are administered subcutaneously and intracutaneously at the trigeminal nerve point. The PIT has been performed three times. with an injection interval of 2-3 weeks. Injections are made at the trigeminal nerve point, based on the Lyftogt book. The NRS score on first injection was changed from 6 to 2, second injection was from 2 to 1, and third injection was 1 before and after injection. The quality of life is better than before. SF-36 questionnaire showed a change from 50-75% on first injection, 75-100% on second injection, and 100% on the third injection. This study showed that PIT can improve patient's pain and patient's quality of life.]]>
Copyrights © 2025
